Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models

BACKGROUND: Mesenchymal stem cells (MSCs) may be one of candidates for disease-modifying therapy in Parkinsonian diseases. As knowledge regarding the therapeutic properties of MSCs accumulates, some obstacles still remain to be overcome, especially, successful clinical translation requires the devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jin Young, Kim, Dong-Yeol, Lee, Jieun, Shin, Yu Jin, Kim, Yi Seul, Lee, Phil Hyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509608/
https://www.ncbi.nlm.nih.gov/pubmed/36153562
http://dx.doi.org/10.1186/s13287-022-03139-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509608/
https://www.ncbi.nlm.nih.gov/pubmed/36153562
http://dx.doi.org/10.1186/s13287-022-03139-w

Ejemplares similares